Long‐term efficacy of rituximab in IgM anti‐myelin‐associated glycoprotein neuropathy: RIMAG follow‐up study

This study stresses the lack of useful clinical scales, sensitive enough to capture small, even meaningful, improvement in IgM anti‐MAG neuropathy.

Source: Journal of the Peripheral Nervous System - January 8, 2016 Category: Neurology Authors: Ruxandra Iancu Ferfoglia, Raquel Guimarães‐Costa, Karine Viala, Lucile Musset, Jean Neil, Benoit Marin, Jean‐Marc Léger Tags: RESEARCH REPORTS Source Type: research